|

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

RECRUITINGSponsored by Francesco De Cobelli
Actively Recruiting
SponsorFrancesco De Cobelli
Started2018-02-28
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this observational study is to collect data on efficacy and safety of microwave ablation (MWA) used to treat subjects with primary and secondary liver malignancies and renal malignancies. The main question it aims to evaluate the short, medium and long-term clinical course of patients treated with MWA. Participants will not alter their normal clinical and therapeutic practice, due to the observational nature of the study, and all data regarding microwave treatments will be collected (including demographic data). follow their normal clinical and therapeutic path

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* \> 18 years with primary or secondary liver tumors or small kidney tumors that are not candidates for surgery or cannot be radically resected by surgery alone
* Primary liver cancer: up to three liver nodules ≤ 3 cm
* Secondary hepatic tumours: up to nodules ≤ 3 cm provided that the objective is complete hepatic clearance Renal tumours: single or multiple (von Hippel Lindau syndrome), \< 4 cm

Exclusion Criteria:

* pregnant women
* non-manageable coagulopathies
* Extended extrahepatic or extrarenal disease
* for liver ablation: presence of bilio-digestive anastomosis

Conditions6

CancerKidney CancerLiver CancerLiver DiseaseLiver Metastasis Colon CancerRenal Cell Carcinoma

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.